Prophylactic fluconazole and candida krusei infections

Janice Y. Tam, Karl G. Blume, Charles G. Prober, René Olivier Casasnovas, Denis Caillot, Eric Solary, Bernard Bonotte, Pascal Chavanet, Alain Bonin, Patrick Camerlynck, Henri Guy, U. Schuler, G. Ehninger, John R. Wingard, William G. Merz, Michael G. Rinaldi, Judith E. Karp, Rein Saral, James W. Hathorn

Résultats de recherche: Contribution à un journalLetterRevue par des pairs

54 Citations (Scopus)

Résumé

To the Editor: In the October 31 issue of the Journal, Wingard et al.* reported the results of their retrospective study of the incidence and types of fungal infections in patients who had leukemia or who had undergone bone marrow transplantation. Some of the patients received no antifungal prophylaxis, whereas others received oral fluconazole, intravenous miconazole, or low-dose intravenous amphotericin B. A twofold greater incidence of colonization and a sevenfold greater frequency of infection caused by Candida krusei were noted in the 84 patients who received prophylactic fluconazole as compared with the 335 patients who did not. Nine of.

langue originaleAnglais
Pages (de - à)891-893
Nombre de pages3
journalNew England Journal of Medicine
Volume326
Numéro de publication13
Les DOIs
étatPublié - 26 mars 1992
Modification externeOui

Contient cette citation